Related Experiment Video
Updated: Apr 4, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Feline leukemia virus-negative acute lymphoid B-cell aleukemic leukemia in a cat with prolonged survival
Jennifer Brodkin1, Nolan Chalifoux1, Olivier Campbell1
1Department of Internal Medicine (Brodkin), Department of Emergency and Critical Care (Chalifoux), and Department of Oncology (Campbell), BluePearl Pet Hospital, Levittown, Pennsylvania, USA.
Abstract:
A 13-year-old feline leukemia virus-negative cat was diagnosed with acute lymphoid B-cell aleukemic leukemia. The diagnosis was based on the combination of pancytopenia, large and atypical round cells present on liver and splenic cytology, bone marrow cytology and histopathology showing a majority nucleated population of atypical blast cells, immunohistochemistry, and a lack of malignant lymphoblasts observed in the peripheral blood. The cat was initially treated with L-asparaginase, vincristine, doxorubicin, cyclophosphamide, and prednisolone, which led to a resolution of the cytopenias. After relapse on Day 242, lomustine was first administered, followed by a modified protocol of vincristine, mitoxantrone, cyclophosphamide, and prednisolone, due to progressive disease. A survival time exceeding 1 y following diagnosis was obtained. This case highlights both a rare, aleukemic form of acute lymphoid leukemia in a feline leukemia virus-negative cat and an atypically prolonged survival time. Key clinical message: Prolonged survival of cats with acute lymphoid aleukemic leukemia is possible with chemotherapy treatment.

